With $130M, Protego pushes forward a new type of amyloidosis drug

Dec 01, 2025

News

PiB-PET/CT detects subtypes in cardiac amyloidosis

Dec 06, 2025

Pfizer reported an ATTR sales decline in the US. Should newer market entrants Alnylam and BridgeBio worry?

Dec 03, 2025

With $130M, Protego pushes forward a new type of amyloidosis drug

Dec 01, 2025

Donegal patient marks five years on life-changing world-first amyloidosis therapy

Nov 25, 2025

From Rare to Recognised: Shining a Light on Amyloidosis

Oct 16, 2025

More in News

Education

Diagnosed With ATTR-CM: What Should I Do Now?

Nov 18, 2025

Amyloidosis Symptoms & Causes (Mayo Clinic)

Nov 12, 2025

Clinical Utility of AI Based Review of Echocardiography for Diagnosis of Cardiac Amyloidosis

Oct 18, 2025

AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy

Oct 17, 2025

Safety and efficacy of elranatamab in patients with relapsed and/or refractory immunoglobulin light-chain amyloidosis

Oct 16, 2025

More in Education

Community Center

A Legacy of Hope: Alison’s Story

Jul 29, 2025

Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MD

Apr 05, 2025

Dottie’s Travel Alert for TAVR Patients

Apr 02, 2025

Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations

Apr 01, 2025

Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025

Mar 31, 2025

More in Community Center

Hot Topics

Healthy Meal Planning: Tips for Older Adults

Mar 12, 2025

An Elderly Mother and an Aging Son: A Journalist’s Caregiving Story

Mar 07, 2025

Supporting Family Caregivers in Providing Care

Mar 04, 2025

Live-In Caregivers for Elderly

Feb 26, 2025

The Hidden Cost of Caregiving: Stress, Anxiety, and Coping Mechanisms

Jan 23, 2025

Video